Literature DB >> 3556315

Immunocytochemical evidence for vasopressin and oxytocin pathways in the hypothalamo-hypophyseal axis of the camel (Camelus dromedarius).

M el May, A el May, C Bouzakoura, P M Dubois.   

Abstract

Immunoperoxidase staining was applied to the hypothalamus and posterior pituitary of the camel. Vasopressin and oxytocin cells and fibers were identified in different nuclei of the hypothalamus. Immunoreactive fiber tracts were followed to the median eminence and the posterior pituitary. In the median eminence, two different pathways were found for vasopressin, one passing to the posterior lobe and the other contacting capillaries of the portal system. The oxytocin antiserum stained one unique pathway in the internal zone on its way to the posterior pituitary. The two immunoreactivities were shown in the posterior lobe of the pituitary, vasopressin staining being the more intense. Relations between these data and the physiology of the camel are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3556315     DOI: 10.1016/0016-6480(87)90276-0

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  2 in total

1.  Seasonal adaptations of the hypothalamo-neurohypophyseal system of the dromedary camel.

Authors:  Fatma Zohra Djazouli Alim; Elena V Romanova; Yea-Ling Tay; Ahmad Yamin Bin Abdul Rahman; Kok-Gan Chan; Kar-Wai Hong; Mark Rogers; Bruce R Southey; Michael P Greenwood; Andre Souza Mecawi; Mohammad Rais Mustafa; Nicole Mahy; Colin Campbell; José Antunes-Rodrigues; Jonathan V Sweedler; David Murphy; Charles C T Hindmarch
Journal:  PLoS One       Date:  2019-06-18       Impact factor: 3.240

2.  The Suprachiasmatic Nucleus of the Dromedary Camel (Camelus dromedarius): Cytoarchitecture and Neurochemical Anatomy.

Authors:  Khalid El Allali; Mohamed R Achaâban; Mohammed Piro; Mohammed Ouassat; Etienne Challet; Mohammed Errami; Nouria Lakhdar-Ghazal; André Calas; Paul Pévet
Journal:  Front Neuroanat       Date:  2017-11-16       Impact factor: 3.856

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.